Literature DB >> 6269968

Loperamide: studies on its mechanism of action.

B K Sandhu, J H Tripp, D C Candy, J T Harries.   

Abstract

The effects of loperamide on net solute and water absorption, and prostaglandin E2 (PGE2) and cholera toxin-induced secretion were studied in the rat jejunum using an in vivo steady-state perfusion technique. Loperamide stimulated absorption of fluid, electrolytes, and glucose and reversed PGE2 and cholera toxin-induced secretion to absorption; this opiate analogue had no effect on cholera toxin stimulation of adenylate cyclase activity or the rise of tissue cyclic AMP (cAMP) concentrations. The opiate antagonist, naloxone, reduced the antisecretory effects of loperamide without affecting tissue levels of cAMP. These results indicate that loperamide inhibits PGE2 and cholera toxin-induced secretion, and that this phenomenon is independent of any direct effect that cholera toxin has on the adenylate cyclase system. The action of naloxone suggests, but does not prove, that loperamide exerts its effect via opiate receptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6269968      PMCID: PMC1420055          DOI: 10.1136/gut.22.8.658

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

Review 1.  Cholera enterotoxin--recent investigations yield insights into transport processes.

Authors:  C C Carpenter
Journal:  Am J Med       Date:  1971-01       Impact factor: 4.965

2.  Inhibition of glucose absorption by prostaglandins E 1 , E 2 and F 2 .

Authors:  I M Coupar; I McColl
Journal:  J Pharm Pharmacol       Date:  1972-03       Impact factor: 3.765

3.  Effect of prostaglandin E 1 on glucose, water, and electrolyte absorption in the human jejunum.

Authors:  C Matuchansky; J J Bernier
Journal:  Gastroenterology       Date:  1973-06       Impact factor: 22.682

4.  Intestinal adenyl-cyclase activity in canine cholera: correlation with fluid accumulation.

Authors:  R L Guerrant; L C Chen; G W Sharp
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

5.  Studies on the effects of unconjugated dihydroxy bile salts on rat small intestinal function in vivo.

Authors:  G E Sladen; J T Harries
Journal:  Biochim Biophys Acta       Date:  1972-11-02

6.  Effects of prostaglandins, theophylline, and cholera exotoxin upon transmucosal water and electrolyte movement in the canine jejunum.

Authors:  N F Pierce; C C Carpenter; H L Elliott; W B Greenough
Journal:  Gastroenterology       Date:  1971-01       Impact factor: 22.682

7.  Interrelationships between the absorptions of glucose, sodium and water by the normal human jejunum.

Authors:  G E Sladen; A M Dawson
Journal:  Clin Sci       Date:  1969-02       Impact factor: 6.124

8.  Effects of prostaglandins and cholera enterotoxin on intestinal mucosal cyclic AMP accumulation. Evidence against an essential role for prostaglandins in the action of toxin.

Authors:  D V Kimberg; M Field; E Gershon; A Henderson
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

9.  Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins.

Authors:  D V Kimberg; M Field; J Johnson; A Henderson; E Gershon
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

10.  The effects of different bile salts on the absorption of fluid, electrolytes, and monosaccharides in the small intestine of the rat in vivo.

Authors:  J T Harries; G E Sladen
Journal:  Gut       Date:  1972-08       Impact factor: 23.059

View more
  30 in total

1.  Effects of the prodrug loperamide oxide, loperamide, and placebo on jejunal motor activity.

Authors:  G Stacher; H Steinringer; C Schneider; G V Vacariu-Granser; F Castiglione; G Gaupmann; U Weber; G Stacher-Janotta
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

Review 2.  Pathogenesis and pharmacology of diarrhea.

Authors:  L Ooms; A Degryse
Journal:  Vet Res Commun       Date:  1986-09       Impact factor: 2.459

3.  Nufenoxole, a new antidiarrhoeal agent, inhibits fluid secretion in the human jejunum.

Authors:  K J Moriarty; D D Rolston; M J Kelly; M Shield; M L Clark
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

4.  Secretagogue-induced changes in membrane calcium permeability in chicken and chinchilla ileal mucosa. Selective inhibition by loperamide.

Authors:  E B Chang; D R Brown; N S Wang; M Field
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

Review 5.  Marasmus--1985.

Authors:  D Barltrop; B K Sandhu
Journal:  Postgrad Med J       Date:  1985-10       Impact factor: 2.401

Review 6.  Protracted diarrhea in infancy.

Authors:  B K Sandhu; P J Milla
Journal:  Indian J Pediatr       Date:  1984 Jan-Feb       Impact factor: 1.967

7.  Loperamide in acute diarrhoea in childhood: results of a double blind, placebo controlled multicentre clinical trial. Diarrhoeal Diseases Study Group (UK).

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10

8.  Inhibition by loperamide of deoxycholic acid induced intestinal secretion.

Authors:  U M Farack; K Loeschke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

9.  Local inhibition of myoelectrical activity of human colon by loperamide.

Authors:  I Altaparmakov; M Wienbeck
Journal:  Dig Dis Sci       Date:  1984-03       Impact factor: 3.199

10.  Characterization of the opiate receptor population mediating inhibition of VIP-induced secretion from the small intestine of the rat.

Authors:  I M Coupar
Journal:  Br J Pharmacol       Date:  1983-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.